2026 Articles
Accepted articles
LC-HRMS detection of three ionizable lipids in equine plasma: surrogate markers for long-term LNP-mediated gene-doping surveillance.
Shimizu Y, Furukawa R, Kikuchi M, Sugai-Bannai M, Hirano-Kodaira M, Tozaki T, Leung GN.
Anal. Bioanal. Chem., DOI 10.1007/s00216-026-06556-5.
Abstract
Direct LC-HRMS/MS characterisation and RT-qPCR detection for potential mRNA-based doping agent.
Yuen BP, Wong KS, Lin VY, Cheung HW, Ho EN, Wong WT.
Anal. Bioanal. Chem., DOI 10.1007/s00216-026-06513-2.
Abstract
Influence of tramadol on the intravenous pharmacokinetics of dipyrone active metabolites in dogs.
Mouta AN, Arcoverde KN, Dos Anjos Honorato R, Fernandes NS, de Oliveira CVA, Mesquita GC, Passos YDB, Araújo-Silva G, de Paula VV.
J. Vet. Pharmacol. Ther., DOI 10.1111/jvp.70073.
Full text
Erythrocyte sequestration of metformin in horses: impact on matrix-specific pharmacokinetics and detection windows.
Jacobs ME, Blea J, Hardy M, McKemie DS, Traynham M, Knych HK.
BMC Vet. Res., DOI 10.1186/s12917-026-05449-0.
Full text
Pharmacokinetics of intramuscularly administered ketamine at subanaesthetic dosage in horses.
Vandaele Z, Flyps J, Cuypers C, De Baere S, Devreese M, Schauvliege S.
J. Vet. Pharmacol. Ther., DOI 10.1111/jvp.70070.
Abstract
Effects of oral single-dose empagliflozin on urinary glucose, serum β-hydroxybutyrate, and plasma empagliflozin concentrations in healthy adult dogs.
Plá Gutierrez AD, M. O'Sullivan L, Côté E, McConkey S, KuKanich B, Martinez SE.
J. Vet. Pharmacol. Ther., DOI 10.1111/jvp.70066.
Full text
Plasma and urinary elimination profiles of medetomidine metabolites in horses for the purpose of doping and medication control.
Minamijima Y, Kuroda T, Maeda Y, Narita S, Yamashita S, Yamada M.
J. Vet. Pharmacol. Ther., DOI 10.1111/jvp.70063.
Abstract
The pharmacokinetics of intravenous and subcutaneous ondansetron in female beagle dogs.
Landau ED, Boege KR, Messenger K, Ballash G, Gustafson D, Pereira CR, Banks K, Aarnes T, Lerche P, Midon M, Muñoz KA.
J. Vet. Pharmacol. Ther., DOI 10.1111/jvp.70058.
Full text
Vonoprazan pharmacokinetics and effects on gastric pH following administration to fed and fasted horses.
Morales CJ, Sykes BW, McKemie DS, Kass PH, Knych HK.
Equine Vet. J., DOI 10.1111/evj.70128.
Full text
Published articles
Pharmacokinetics of ilunocitinib, a new Janus kinase inhibitor, in dogs.
Boerngen K, Patel Y, Pittorino M, Toutain CE.
J. Vet. Pharmacol. Ther., 2026, 49, 7-16.
Full text
Determination and pharmacokinetic of peiminine in beagle dogs by UPLC-MS/MS.
Cheng Q, Peng X, Li X, Jia X.
Int. J. Anal. Chem., 2026, 2026, 4144078.
Full text
Metabolite profiling and identification of semaglutide in liver S9 across species and rat plasma.
Cong Y, Tang C, Li Z, Gao Y, Chen L, Xu H, Diao X.
Biomed Chromatogr., 2026, 40, e70415.
Abstract
Comparative pharmacokinetics of intranasal or intramuscular atipamezole in unsedated dogs and efficacy for reversal of xylazine sedation.
Cowan VE, Mitcham VR, Michel DL, Lyons C, Kennedy J, Reyes Morales YC, Loewen JM, Chicoine AL.
J. Vet. Pharmacol. Ther., 2026, 49, 257-266.
Full text
Differences in plasma exposure of cannabidiol and cannabidiolic acid following oral administration to horses.
Ekstrand C, Michanek P, Hernlund E, Gehring R, Spjut K, Salomonsson M.
J. Vet. Pharmacol. Ther., 2026, 49, 22-32.
Full text
Bioavailability of oral ondansetron in dogs: A crossover study.
Garrick A, Zersen K, Gustafson D, Quimby J, Diaz A, Shropshire S.
J. Vet. Pharmacol. Ther., 2026, 49, 17-21.
Full text
Exposure to subcutaneously administered butorphanol in horses pre-treated with detomidine or detomidine-vatinoxan.
Honkavaara JM, Karikoski NP, Palvas L, Pypendop BH, Rinne VM, Raekallio MR.
J. Vet. Pharmacol. Ther., 2026, 49, 289-294.
Full text
A first report of the misuse of a novel synthetic glucocorticoid, 9α-fluoro-6α-methylprednisolone, in camel racing.
Ishii H, Basgallop NJ, Kelly RP, Todoroki K, Alshamsi NS, McKinney AR.
Drug Test. Anal., 2026, 18, 270-286.
Abstract
Metformin in the horse: Pharmacokinetics and detection times using Monte Carlo simulations.
Jacobs ME, Blea J, Hardy M, McKemie DS, Traynham M, Knych HK.
Drug Test. Anal., 2026, 18, 139-148.
Full text
Analytical challenges and emerging detection strategies of synthetic cannabinoids in horse doping control.
Kabil E, Ural MN, Göktaş EF.
Biomed. Chomatogr., 2026, 40, e70432.
Abstract
Pharmacokinetics of remimazolam versus midazolam after intravenous administration to horses.
Kawashima M, Kuroda T, Minamijima Y, Yamazaki Y, Mita H, Nomura M, Ohta M.
J. Vet. Pharmacol. Ther., 2026, 49, 94-98.
Abstract
A meta-analysis of international flunixin pharmacokinetics in horses: Toward regulatory harmonization and individualized detection times using Bayesian paradigm.
Kuroda T, Knych HK, Noble GK, Minamijima Y, Leung GNW, Nomura M, Mizobe F, Ishikawa Y, Kusano K, Toutain PL.
Drug Test. Anal., 2026, 18, 32-50.
Full text
Pharmacokinetics of topical administration of altrenogest in mares and implications for human health.
Loy J, Sornalingam K, Cawley A, Scrivener C, Keledjian J, Noble GK.
J. Vet. Pharmacol. Ther., 2026, 49, 274-281.
Full text
Plasma and urine pharmacokinetics of intravenous pridinol in Thoroughbreds for its medication control.
Minamijima Y, Kuroda T, Okano A, Wakuno A, Yuasa R, Ishikawa Y, Nomura M, Kinoshita K, Yamada M.
J. Vet. Pharmacol. Ther., 2026, 49, 1-6.
Abstract
Plasma concentrations following oral administration of two different forms of resveratrol in horses.
Mochal-King C, Strunk R, Paul L.
J. Equine Vet. Sci., 2026, 161, 105859.
Abstract
Sensitive and selective quantification of elcatonin in equine plasma and urine using LC-FAIMS-MS/MS.
Ohnuma K, Fukazawa M, Uchida T, Kato T, Sugai-Bannai M, Shibuya M, Yamada M, Hirano-Kodaira M.
J. Pharm. Biomed. Anal., 2026, 279, 117551.
Abstract
Plasma pharmacokinetics of topical 0.1% diclofenac sodium and 0.5% ketorolac tromethamine in dogs.
Peraza J, Ross MK, Langston VC, Wills R, Fischer D, Cassen C, Betbeze C.
Vet. Opthalmol., 2026, 29, e70105.
Abstract
Pharmacokinetics and safety of a single subcutaneous or intramuscular dose of ketamine in healthy horses.
Rangel A, Sellon DC, Sanz MG, Pinnell E, Pietras ZM, Villarino NF.
J. Vet. Pharmacol. Ther., 2026, 49, 141-149.
Full text
Gene editing and the future of Thoroughbred breeding and racing.
Ryder E, Given J, Hamilton N.
Drug Test. Anal., 2026, 18, 646-651.
Abstract
Efficacy, pharmacokinetics and safety of liposomal synthetic cannabidiol injected subcutaneously in dogs: a randomized, blinded, placebo-controlled, crossover clinical trial.
Shilo-Benjamini Y, Milgram J, Lavy E, Quint M, Barasch D, Cern A, Barenholz Y.
Front. Vet. Sci., 2026, 12, 1746266.
Full text
Supramolecular solvent extraction for doping control analysis of prohibited substances in horse urine.
So YM, Kwok WH, Yuen SMS, Wong COL, Ho ENM.
Drug Test. Anal., 2026, 18, 652-668.
Abstract
Detection of nandrolone decanoate and its metabolites in equine hair after intramuscular administration.
So YM, Kwok WH, Yuen SMS, Wong COL, Wan TSM, Ho ENM.
Drug Test. Anal., 2026, 18, 149-158.
Abstract
Pharmacokinetics and anti-inflammatory effects of intramuscular betamethasone in exercised Thoroughbred horses.
Sullivan J, Blea J, McKemie DS, Kass PH, Knych HK.
J. Vet. Pharmacol. Ther., 2026, 49, 295-305.
Full text
Special issue "gene doping control".
Tozaki T.
Int. J. Mol. Sci., 2026, 27, 2631.
Full text
Pharmacokinetics of ropivacaine after intraperitoneal instillation in anaesthetized dogs: a randomized clinical trial.
Verdier N, Hummel K, Al-Jalali V, Claaßen S, Donati PA, Portela DA, Razzazi-Fazeli E, Mosing M.
Vet. Anaesth. Analg., 2026, 53, 101146.
Full text
Single-dose pharmacokinetics of intranasal levetiracetam in healthy dogs.
Wagner JL, Foss KD, Reinhart JM, Forsythe LE.
J. Vet. Pharmacol. Ther., 2026, 49, 110-119.
Full text
Population pharmacokinetics of sildenafil in dogs with naturally occurring pulmonary hypertension.
Yata M, DeFrancesco TC, Bonagura JD, Papich MG.
J. Vet. Pharmacol. Ther., 2026, 49, 267-273.
Full text
